Ionis Pharmaceuticals, Inc. (IONS)
USD 28.68
(2.8%)
USD 28.68
(2.8%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 787.64 Million USD | 34.18% |
| 2022 | 587 Million USD | -27.53% |
| 2021 | 810 Million USD | 11.11% |
| 2020 | 729 Million USD | -35.08% |
| 2019 | 1.12 Billion USD | 87.27% |
| 2018 | 599.67 Million USD | 18.12% |
| 2017 | 507.66 Million USD | 46.46% |
| 2016 | 346.62 Million USD | 22.18% |
| 2015 | 283.7 Million USD | 32.47% |
| 2014 | 214.16 Million USD | 45.41% |
| 2013 | 147.28 Million USD | 44.33% |
| 2012 | 102.04 Million USD | 2.99% |
| 2011 | 99.08 Million USD | -8.65% |
| 2010 | 108.47 Million USD | -10.8% |
| 2009 | 121.6 Million USD | 13.44% |
| 2008 | 107.19 Million USD | 53.96% |
| 2007 | 69.62 Million USD | 183.8% |
| 2006 | 24.53 Million USD | -38.87% |
| 2005 | 40.13 Million USD | -5.84% |
| 2004 | 42.62 Million USD | -14.73% |
| 2003 | 49.99 Million USD | -37.65% |
| 2002 | 80.17 Million USD | 50.51% |
| 2001 | 53.27 Million USD | 43.0% |
| 2000 | 37.25 Million USD | 9.9% |
| 1999 | 33.9 Million USD | -13.52% |
| 1998 | 39.2 Million USD | 20.62% |
| 1997 | 32.5 Million USD | 43.81% |
| 1996 | 22.6 Million USD | 73.85% |
| 1995 | 13 Million USD | 28.71% |
| 1994 | 10.1 Million USD | -16.53% |
| 1993 | 12.1 Million USD | 39.08% |
| 1992 | 8.7 Million USD | 38.1% |
| 1991 | 6.3 Million USD | 215.0% |
| 1990 | 2 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 225.25 Million USD | 88.5% |
| 2024 Q1 | 119.49 Million USD | -63.18% |
| 2023 Q2 | 188 Million USD | 43.51% |
| 2023 Q4 | 324.5 Million USD | 125.35% |
| 2023 Q3 | 144 Million USD | -23.4% |
| 2023 Q1 | 131 Million USD | -13.82% |
| 2023 FY | 787.64 Million USD | 34.18% |
| 2022 Q4 | 152 Million USD | -4.86% |
| 2022 Q3 | 159.76 Million USD | 19.42% |
| 2022 Q1 | 141.91 Million USD | -67.75% |
| 2022 Q2 | 133.79 Million USD | -5.73% |
| 2022 FY | 587 Million USD | -27.53% |
| 2021 Q3 | 133.09 Million USD | 5.84% |
| 2021 Q4 | 440 Million USD | 230.6% |
| 2021 Q1 | 111.6 Million USD | -61.51% |
| 2021 Q2 | 125.75 Million USD | 12.67% |
| 2021 FY | 810 Million USD | 11.11% |
| 2020 Q1 | 133.36 Million USD | -73.0% |
| 2020 Q2 | 145.53 Million USD | 9.13% |
| 2020 Q3 | 160.07 Million USD | 9.99% |
| 2020 FY | 729 Million USD | -35.08% |
| 2020 Q4 | 290 Million USD | 81.16% |
| 2019 Q3 | 167.89 Million USD | 2.37% |
| 2019 Q4 | 494 Million USD | 194.24% |
| 2019 Q1 | 297.21 Million USD | 54.71% |
| 2019 FY | 1.12 Billion USD | 87.27% |
| 2019 Q2 | 164 Million USD | -44.82% |
| 2018 Q1 | 144.41 Million USD | -16.18% |
| 2018 Q3 | 145.39 Million USD | 23.48% |
| 2018 Q4 | 192.11 Million USD | 32.13% |
| 2018 Q2 | 117.74 Million USD | -18.47% |
| 2018 FY | 599.67 Million USD | 18.12% |
| 2017 Q4 | 172.29 Million USD | 42.5% |
| 2017 Q2 | 104.15 Million USD | -5.58% |
| 2017 Q1 | 110.3 Million USD | -31.21% |
| 2017 FY | 507.66 Million USD | 46.46% |
| 2017 Q3 | 120.91 Million USD | 16.09% |
| 2016 Q3 | 110.92 Million USD | 188.35% |
| 2016 Q4 | 160.34 Million USD | 44.55% |
| 2016 FY | 346.62 Million USD | 22.18% |
| 2016 Q1 | 36.87 Million USD | -28.5% |
| 2016 Q2 | 38.47 Million USD | 4.33% |
| 2015 Q3 | 49.12 Million USD | -59.21% |
| 2015 FY | 283.7 Million USD | 32.47% |
| 2015 Q1 | 62.58 Million USD | -26.25% |
| 2015 Q4 | 51.57 Million USD | 4.99% |
| 2015 Q2 | 120.42 Million USD | 92.43% |
| 2014 FY | 214.16 Million USD | 45.41% |
| 2014 Q3 | 44.06 Million USD | -22.8% |
| 2014 Q4 | 84.86 Million USD | 92.59% |
| 2014 Q2 | 57.07 Million USD | 102.68% |
| 2014 Q1 | 28.16 Million USD | -33.34% |
| 2013 Q2 | 38.09 Million USD | -12.15% |
| 2013 Q1 | 43.36 Million USD | 118.19% |
| 2013 FY | 147.28 Million USD | 44.33% |
| 2013 Q4 | 42.24 Million USD | 79.13% |
| 2013 Q3 | 23.58 Million USD | -38.08% |
| 2012 Q2 | 47.34 Million USD | 103.74% |
| 2012 Q1 | 23.23 Million USD | -28.29% |
| 2012 Q3 | 11.6 Million USD | -75.49% |
| 2012 Q4 | 19.87 Million USD | 71.3% |
| 2012 FY | 102.04 Million USD | 2.99% |
| 2011 Q2 | 24.82 Million USD | 17.38% |
| 2011 Q3 | 20.71 Million USD | -16.56% |
| 2011 FY | 99.08 Million USD | -8.65% |
| 2011 Q4 | 32.4 Million USD | 56.44% |
| 2011 Q1 | 21.14 Million USD | -19.96% |
| 2010 Q1 | 29.92 Million USD | -7.24% |
| 2010 FY | 108.47 Million USD | -10.8% |
| 2010 Q2 | 23.5 Million USD | -21.46% |
| 2010 Q3 | 28.62 Million USD | 21.79% |
| 2010 Q4 | 26.42 Million USD | -7.7% |
| 2009 Q3 | 26.77 Million USD | -13.62% |
| 2009 FY | 121.6 Million USD | 13.44% |
| 2009 Q4 | 32.26 Million USD | 20.51% |
| 2009 Q2 | 30.99 Million USD | -1.85% |
| 2009 Q1 | 31.57 Million USD | 52.83% |
| 2008 Q2 | 32.96 Million USD | 54.36% |
| 2008 Q1 | 21.35 Million USD | -13.64% |
| 2008 FY | 107.19 Million USD | 53.96% |
| 2008 Q3 | 32.21 Million USD | -2.26% |
| 2008 Q4 | 20.66 Million USD | -35.87% |
| 2007 Q2 | 3.81 Million USD | 55.63% |
| 2007 Q4 | 24.72 Million USD | -35.99% |
| 2007 Q3 | 38.63 Million USD | 913.14% |
| 2007 Q1 | 2.45 Million USD | -79.49% |
| 2007 FY | 69.62 Million USD | 183.8% |
| 2006 FY | 24.53 Million USD | -38.87% |
| 2006 Q4 | 11.94 Million USD | 267.2% |
| 2006 Q3 | 3.25 Million USD | -25.65% |
| 2006 Q2 | 4.37 Million USD | -11.76% |
| 2006 Q1 | 4.95 Million USD | -66.14% |
| 2005 Q1 | 7.44 Million USD | -34.63% |
| 2005 Q3 | 7.45 Million USD | -29.59% |
| 2005 Q2 | 10.59 Million USD | 42.33% |
| 2005 FY | 40.13 Million USD | -5.84% |
| 2005 Q4 | 14.64 Million USD | 96.31% |
| 2004 Q3 | 9.09 Million USD | -7.62% |
| 2004 Q1 | 12.3 Million USD | 26.85% |
| 2004 FY | 42.62 Million USD | -14.73% |
| 2004 Q2 | 9.84 Million USD | -20.0% |
| 2004 Q4 | 11.38 Million USD | 25.21% |
| 2003 Q3 | 11.29 Million USD | -24.79% |
| 2003 Q4 | 9.69 Million USD | -14.12% |
| 2003 Q2 | 15.01 Million USD | 7.41% |
| 2003 Q1 | 13.98 Million USD | -36.04% |
| 2003 FY | 49.99 Million USD | -37.65% |
| 2002 FY | 80.17 Million USD | 50.51% |
| 2002 Q1 | 17.95 Million USD | -17.41% |
| 2002 Q3 | 20.3 Million USD | 1.19% |
| 2002 Q4 | 21.85 Million USD | 7.68% |
| 2002 Q2 | 20.06 Million USD | 11.7% |
| 2001 Q3 | 19.3 Million USD | 154.27% |
| 2001 FY | 53.27 Million USD | 43.0% |
| 2001 Q4 | 21.74 Million USD | 12.64% |
| 2001 Q2 | 7.59 Million USD | 63.87% |
| 2001 Q1 | 4.63 Million USD | -41.62% |
| 2000 Q3 | 18.28 Million USD | 161.7% |
| 2000 Q1 | 4.05 Million USD | -57.33% |
| 2000 Q2 | 6.98 Million USD | 72.3% |
| 2000 FY | 37.25 Million USD | 9.9% |
| 2000 Q4 | 7.93 Million USD | -56.59% |
| 1999 Q4 | 9.5 Million USD | -10.38% |
| 1999 Q3 | 10.6 Million USD | 47.22% |
| 1999 Q2 | 7.2 Million USD | 9.09% |
| 1999 FY | 33.9 Million USD | -13.52% |
| 1999 Q1 | 6.6 Million USD | -13.16% |
| 1998 Q2 | 5.8 Million USD | 0.0% |
| 1998 FY | 39.2 Million USD | 20.62% |
| 1998 Q4 | 7.6 Million USD | -61.62% |
| 1998 Q3 | 19.8 Million USD | 241.38% |
| 1998 Q1 | 5.8 Million USD | -38.3% |
| 1997 Q3 | 12.6 Million USD | 117.24% |
| 1997 FY | 32.5 Million USD | 43.81% |
| 1997 Q1 | 4.6 Million USD | -28.13% |
| 1997 Q2 | 5.8 Million USD | 26.09% |
| 1997 Q4 | 9.4 Million USD | -25.4% |
| 1996 FY | 22.6 Million USD | 73.85% |
| 1996 Q4 | 6.4 Million USD | 25.49% |
| 1996 Q3 | 5.1 Million USD | 8.51% |
| 1996 Q2 | 4.7 Million USD | -26.56% |
| 1996 Q1 | 6.4 Million USD | 88.24% |
| 1995 Q1 | 2.6 Million USD | 230.0% |
| 1995 Q4 | 3.4 Million USD | -8.11% |
| 1995 Q2 | 3.3 Million USD | 26.92% |
| 1995 Q3 | 3.7 Million USD | 12.12% |
| 1995 FY | 13 Million USD | 28.71% |
| 1994 FY | 10.1 Million USD | -16.53% |
| 1994 Q4 | -2 Million USD | -162.5% |
| 1994 Q2 | 3.1 Million USD | 19.23% |
| 1994 Q1 | 2.6 Million USD | -10.34% |
| 1994 Q3 | 3.2 Million USD | 3.23% |
| 1993 Q4 | 2.9 Million USD | -12.12% |
| 1993 FY | 12.1 Million USD | 39.08% |
| 1993 Q1 | 2.7 Million USD | 350.0% |
| 1993 Q2 | 3.2 Million USD | 18.52% |
| 1993 Q3 | 3.3 Million USD | 3.13% |
| 1992 Q4 | 600 Thousand USD | -81.82% |
| 1992 FY | 8.7 Million USD | 38.1% |
| 1992 Q2 | 2.3 Million USD | -8.0% |
| 1992 Q1 | 2.5 Million USD | 212.5% |
| 1992 Q3 | 3.3 Million USD | 43.48% |
| 1991 FY | 6.3 Million USD | 215.0% |
| 1991 Q3 | 2 Million USD | 33.33% |
| 1991 Q1 | 1.5 Million USD | 200.0% |
| 1991 Q2 | 1.5 Million USD | 0.0% |
| 1991 Q4 | 800 Thousand USD | -60.0% |
| 1990 Q2 | 500 Thousand USD | 0.0% |
| 1990 FY | 2 Million USD | 0.0% |
| 1990 Q1 | 500 Thousand USD | 0.0% |
| 1990 Q3 | 500 Thousand USD | 0.0% |
| 1990 Q4 | 500 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Agenus Inc. | 156.31 Million USD | -403.888% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -521520.53% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -2184.558% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| MiMedx Group, Inc. | 321.47 Million USD | -145.009% |
| Novavax, Inc. | 983.7 Million USD | 19.931% |
| Seer, Inc. | 15.18 Million USD | -5088.032% |
| Acelyrin, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | -380.525% |
| IO Biotech, Inc. | - USD | -Infinity% |
| Ardelyx, Inc. | 124.45 Million USD | -532.872% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -3694.792% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Fortress Biotech, Inc. | 84.51 Million USD | -831.983% |
| Fortress Biotech, Inc. | 84.51 Million USD | -831.983% |
| Geron Corporation | 237 Thousand USD | -332240.506% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -227.184% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -3812.996% |
| Incyte Corporation | 3.69 Billion USD | 78.687% |
| Innoviva, Inc. | 310.46 Million USD | -153.701% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 83.57 Million USD | -842.5% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -499.82% |
| MEI Pharma, Inc. | 65.29 Million USD | -1106.253% |
| NextCure, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 58.46 Thousand USD | -1347111.152% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -100237.197% |
| GlycoMimetics, Inc. | 10 Thousand USD | -7876370.0% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -3268.172% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -12552.964% |
| Pharming Group N.V. | 245.31 Million USD | -221.074% |
| ContextLogic Inc. | 287 Million USD | -174.441% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -6439.203% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -573.882% |
| AlloVir, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -2441.699% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -30655.447% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -56975.87% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -15752840.0% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -510.518% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Chimerix, Inc. | 324 Thousand USD | -243000.926% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 371.2 Million USD | -112.186% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -595.156% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -115390.762% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -1739.867% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Precision BioSciences, Inc. | 48.72 Million USD | -1516.449% |
| Dyadic International, Inc. | 2.89 Million USD | -27071.429% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -2389.245% |
| Akebia Therapeutics, Inc. | 194.62 Million USD | -304.704% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | 56.919% |
| Aptorum Group Limited | 431.37 Thousand USD | -182488.588% |
| Bicycle Therapeutics plc | 26.97 Million USD | -2819.806% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -9475.091% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -302259.693% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.66 Billion USD | 52.649% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -15271.721% |
| Jaguar Health, Inc. | 9.76 Million USD | -7969.327% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -73926.974% |
| AbCellera Biologics Inc. | 38.02 Million USD | -1971.393% |
| PureTech Health plc | 3.33 Million USD | -23553.063% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | -346.938% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -98110.349% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -3134.159% |
| AnaptysBio, Inc. | 17.15 Million USD | -4490.82% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 57.3 Million USD | -1274.458% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -1153.437% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -50585.135% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -9644.488% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -8870.923% |
| ImmuCell Corporation | 17.47 Million USD | -4408.138% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -185665.802% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -4034.847% |
| Opthea Limited | 261.85 Thousand USD | -300690.502% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -8138.985% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -7827.204% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -1139.745% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -43658.167% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | -97.8% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -28437.935% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -93739.108% |
| Century Therapeutics, Inc. | 2.23 Million USD | -35141.477% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -3641.969% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -678.2% |
| Autolus Therapeutics plc | 1.69 Million USD | -46286.749% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -1611.606% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -1158204.412% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | -362.571% |
| GRI Bio, Inc. | 21.76 Million USD | -3518.537% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -30909.895% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -36878.732% |
| INmune Bio, Inc. | 155 Thousand USD | -508059.355% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -519.98% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -35078.659% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -78664.7% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -9087.531% |
| Coherus BioSciences, Inc. | 257.24 Million USD | -206.187% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -22404.2% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -49751.076% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -10039.637% |
| Histogen Inc. | 3.76 Million USD | -20798.037% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -134948.891% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -722511.927% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -200986.815% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -2224.883% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -11393.463% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | -399.307% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -540124.28% |
| Apollomics, Inc. | 821 Thousand USD | -95837.515% |
| Amarin Corporation plc | 306.91 Million USD | -156.637% |
| Mesoblast Limited | 5.9 Million USD | -13245.425% |
| Turnstone Biologics Corp. | 19.3 Million USD | -3979.804% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -902.197% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | -348.768% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.83 Billion USD | 56.964% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -923.091% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | -98.604% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -59077.085% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -462.963% |
| Insmed Incorporated | 305.2 Million USD | -158.069% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -4115.172% |
| OmniAb, Inc. | 34.16 Million USD | -2205.488% |
| Alector, Inc. | 97.06 Million USD | -711.489% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -523.508% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -764605.825% |
| Zai Lab Limited | 266.71 Million USD | -195.31% |
| Revance Therapeutics, Inc. | 234.04 Million USD | -236.544% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -605782.308% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -4414.513% |
| Veracyte, Inc. | 361.05 Million USD | -118.154% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -17031.215% |
| FibroGen, Inc. | 147.75 Million USD | -433.087% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -532796.045% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | 79.457% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -187435.0% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | -106.848% |
| TG Therapeutics, Inc. | 233.66 Million USD | -237.088% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | 74.666% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -50455.006% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -2206.096% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -828.621% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -1271.634% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | -81.381% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -1659.869% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | -137.664% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -1427313.918% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -2928.946% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -8751533.333% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -23687.839% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | 93.995% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -644920.145% |
| Pluri Inc. | 326 Thousand USD | -241509.509% |
| Prothena Corporation plc | 91.37 Million USD | -762.041% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -1206.626% |
| Celularity Inc. | 22.77 Million USD | -3358.992% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -14246.94% |
| MeiraGTx Holdings plc | 14.01 Million USD | -5519.227% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | -215.781% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -1132.528% |
| Blueprint Medicines Corporation | 249.38 Million USD | -215.842% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -10692.642% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -2071.322% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -15666.648% |
| Cytokinetics, Incorporated | 7.53 Million USD | -10360.12% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -37671.146% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -531.153% |
| Evogene Ltd. | 5.64 Million USD | -13865.372% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -7781.987% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -8366.591% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -16309.313% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -2056.342% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -250742.994% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -39282.35% |
| MediciNova, Inc. | 1 Million USD | -78664.7% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -32088.271% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -4615469.88% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | -191.074% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | 16.013% |
| Mereo BioPharma Group plc | 10 Million USD | -7776.47% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -13674.869% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -3700.835% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | -191.442% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -27980.107% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | -63.285% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -829002.105% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -16454.161% |
| Kezar Life Sciences, Inc. | 7 Million USD | -11152.1% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -3656.424% |
| aTyr Pharma, Inc. | 353 Thousand USD | -223029.462% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -4972.104% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -250742.994% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -6531511.245% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | 5.017% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -348095.908% |
| UroGen Pharma Ltd. | 82.71 Million USD | -852.265% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -412.354% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -2848532.911% |
| Orgenesis Inc. | 530 Thousand USD | -148512.642% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | -367.896% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -310519.427% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | -308.87% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -348095.908% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -4615469.88% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -52304.99% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -15033.22% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -7087.216% |
| scPharmaceuticals Inc. | 13.59 Million USD | -5694.505% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -7758.396% |
| Daré Bioscience, Inc. | 2.8 Million USD | -27951.256% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -427969.022% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | 67.966% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -6701.788% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -1212.745% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -2570.261% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | 67.442% |
| DBV Technologies S.A. | 15.72 Million USD | -4907.929% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | 88.498% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -9738.209% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -442.315% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -7706.988% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -11343.368% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -1240.699% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -121982.502% |
| Adagene Inc. | 18.11 Million USD | -4248.88% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -72695.471% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | -172.594% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | -215.049% |
| SciSparc Ltd. | 2.87 Million USD | -27258.354% |
| Vericel Corporation | 197.51 Million USD | -298.776% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -13240.904% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -1221.422% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -2983.25% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -714.232% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -684.611% |
| ADMA Biologics, Inc. | 258.21 Million USD | -205.035% |
| Clene Inc. | 654 Thousand USD | -120335.321% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -3028.306% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -1667.015% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -1475.294% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -736018.692% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -813.956% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -1077215.625% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -1247.718% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -6598.818% |
| Trevena, Inc. | 3.12 Million USD | -25104.704% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | -8.426% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -12426.193% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -9900.597% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -126531.35% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -14373.484% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -1022.916% |
| Celularity Inc. | 22.77 Million USD | -3358.992% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -19527.386% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -503449.441% |
| Cibus, Inc. | 1.81 Million USD | -43248.762% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -21779.083% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -10896.049% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -40837.994% |
| Eyenovia, Inc. | 3787.00 USD | -20798606.1% |
| Puma Biotechnology, Inc. | 235.63 Million USD | -234.263% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -613.972% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -161303.074% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -894.454% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -86928.106% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -11536.091% |
| Royalty Pharma plc | 2.35 Billion USD | 66.548% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -107227.718% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -2037.151% |
| Humacyte, Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -463221.765% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -65319.186% |
| Notable Labs, Ltd. | 310 Thousand USD | -253979.677% |
| Liquidia Corporation | 17.48 Million USD | -4403.928% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -72695.471% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -4241.806% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -42201.128% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -45891.434% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | 66.159% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -1092306.591% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -16454.161% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -2625390.0% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -4871.577% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -1117.327% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -184793.662% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | -97.229% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -2254.066% |
| Peak Bio, Inc. | 367.87 Thousand USD | -214006.073% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -2768.239% |
| Benitec Biopharma Inc. | 216 Thousand USD | -364551.389% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -88799.21% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | 35.771% |
| Immunome, Inc. | 14.01 Million USD | -5518.826% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -47434.52% |
| CervoMed Inc. | 7.14 Million USD | -10923.948% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -15931.895% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -27771.444% |
| Moolec Science SA | 905.04 Thousand USD | -86928.106% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -94567.973% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -31917.533% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -35653.382% |
| Lumos Pharma, Inc. | 2.05 Million USD | -38303.072% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -1834.054% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -37671.146% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -386001.471% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -656272.5% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -314958.8% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | -108.533% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | -322.616% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -1869.118% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -66144.491% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -4997.709% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -138083.684% |
| HCW Biologics Inc. | 2.84 Million USD | -27616.541% |
| XOMA Corporation | 4.75 Million USD | -16454.161% |
| Nektar Therapeutics | 90.12 Million USD | -773.979% |
| Arvinas, Inc. | 78.5 Million USD | -903.372% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -1692.266% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -25357.24% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -120335.321% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -44882.696% |
| Synlogic, Inc. | 3.37 Million USD | -23265.381% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -214006.073% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -3849.491% |
| Krystal Biotech, Inc. | 50.69 Million USD | -1453.575% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -439.362% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -14360.198% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -175081.766% |
| MannKind Corporation | 198.96 Million USD | -295.878% |
| Ikena Oncology, Inc. | 9.16 Million USD | -8498.766% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -594.268% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | -176.229% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -19691075.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -1470.426% |
| REGENXBIO Inc. | 90.24 Million USD | -772.816% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -35212.259% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -10574.17% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -104224.106% |
| Longeveron Inc. | 709 Thousand USD | -110992.666% |
| Repare Therapeutics Inc. | 51.13 Million USD | -1440.389% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | 36.651% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -6701.788% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -374970.0% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | 92.019% |
| Denali Therapeutics Inc. | 330.53 Million USD | -138.297% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -4733.092% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -29039.734% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -917.264% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -516627.022% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -5179.489% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -116588.444% |
| OmniAb, Inc. | 34.16 Million USD | -2205.488% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -3606.225% |
| Lipocine Inc. | -2.85 Million USD | 27728.807% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -35078.659% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -854.596% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -811.049% |
| Ocugen, Inc. | 6.03 Million USD | -12949.155% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -68035.554% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -2082.815% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -13022.625% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -124310.758% |
| Dominari Holdings Inc. | 2.03 Million USD | -38529.083% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | 32.044% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -2836.461% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | -35.329% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -6153.648% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -165025.157% |
| Iterum Therapeutics plc | - USD | -Infinity% |